125 related articles for article (PubMed ID: 34998973)
1. Brusatol has therapeutic efficacy in non-small cell lung cancer by targeting Skp1 to inhibit cancer growth and metastasis.
Xing S; Nong F; Wang Y; Huang D; Qin J; Chen YF; He DH; Wu PE; Huang H; Zhan R; Xu H; Liu YQ
Pharmacol Res; 2022 Feb; 176():106059. PubMed ID: 34998973
[TBL] [Abstract][Full Text] [Related]
2. Phytochemical library screening reveals betulinic acid as a novel Skp2-SCF E3 ligase inhibitor in non-small cell lung cancer.
He DH; Chen YF; Zhou YL; Zhang SB; Hong M; Yu X; Wei SF; Fan XZ; Li SY; Wang Q; Lu Y; Liu YQ
Cancer Sci; 2021 Aug; 112(8):3218-3232. PubMed ID: 34080260
[TBL] [Abstract][Full Text] [Related]
3. Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors.
Liu YQ; Wang XL; Cheng X; Lu YZ; Wang GZ; Li XC; Zhang J; Wen ZS; Huang ZL; Gao QL; Yang LN; Cheng YX; Tao SC; Liu J; Zhou GB
Oncotarget; 2015 Oct; 6(33):34953-67. PubMed ID: 26474281
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.
Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI
Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor.
Cheng X; Liu YQ; Wang GZ; Yang LN; Lu YZ; Li XC; Zhou B; Qu LW; Wang XL; Cheng YX; Liu J; Tao SC; Zhou GB
Oncotarget; 2017 Jan; 8(2):2681-2693. PubMed ID: 27835873
[TBL] [Abstract][Full Text] [Related]
6. Stratifin Inhibits SCF
Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of Ser72 is dispensable for Skp2 assembly into an active SCF ubiquitin ligase and its subcellular localization.
Bashir T; Pagan JK; Busino L; Pagano M
Cell Cycle; 2010 Mar; 9(5):971-4. PubMed ID: 20160477
[TBL] [Abstract][Full Text] [Related]
9. Ethanol Extract of Citrus grandis 'Tomentosa' Exerts Anticancer Effects by Targeting Skp2/p27 Pathway in Non-Small Cell Lung Cancer.
Huang D; Wu PE; Chen ZJ; Pang YC; Xu ZW; Tan J; Jiang ZH; Yang BB; Zhan R; Xu H; Liu YQ
Mol Nutr Food Res; 2023 Sep; 67(18):e2300061. PubMed ID: 37436082
[TBL] [Abstract][Full Text] [Related]
10. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulations elucidate the mode of protein recognition by Skp1 and the F-box domain in the SCF complex.
Chandra Dantu S; Nathubhai Kachariya N; Kumar A
Proteins; 2016 Jan; 84(1):159-71. PubMed ID: 26573739
[TBL] [Abstract][Full Text] [Related]
12. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics and chemical library screens reveal a novel SCF
Malek E; Abdel-Malek MA; Jagannathan S; Vad N; Karns R; Jegga AG; Broyl A; van Duin M; Sonneveld P; Cottini F; Anderson KC; Driscoll JJ
Leukemia; 2017 Mar; 31(3):645-653. PubMed ID: 27677741
[TBL] [Abstract][Full Text] [Related]
14. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163.
Su L; Han D; Wu J; Huo X
Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C.
Cheng C; Yuan F; Chen XP; Zhang W; Zhao XL; Jiang ZP; Zhou HH; Zhou G; Cao S
Biomed Pharmacother; 2021 Oct; 142():111652. PubMed ID: 34112534
[TBL] [Abstract][Full Text] [Related]
16. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes.
Yokoi S; Yasui K; Mori M; Iizasa T; Fujisawa T; Inazawa J
Am J Pathol; 2004 Jul; 165(1):175-80. PubMed ID: 15215173
[TBL] [Abstract][Full Text] [Related]
17. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
Bornstein G; Ganoth D; Hershko A
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
[TBL] [Abstract][Full Text] [Related]
18. Targeted Inhibition of the E3 Ligase SCF
Zhao H; Iqbal NJ; Sukrithan V; Nicholas C; Xue Y; Yu C; Locker J; Zou J; Schwartz EL; Zhu L
Cancer Res; 2020 Jun; 80(11):2355-2367. PubMed ID: 32265224
[TBL] [Abstract][Full Text] [Related]
19. Activation of ubiquitin ligase SCF(Skp2) by Cks1: insights from hydrogen exchange mass spectrometry.
Yao ZP; Zhou M; Kelly SE; Seeliger MA; Robinson CV; Itzhaki LS
J Mol Biol; 2006 Oct; 363(3):673-86. PubMed ID: 16979657
[TBL] [Abstract][Full Text] [Related]
20. USP2 is an SKP2 deubiquitylase that stabilizes both SKP2 and its substrates.
Zhang F; Zhao Y; Sun Y
J Biol Chem; 2021 Oct; 297(4):101109. PubMed ID: 34425107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
